The Company will no longer use Rats but instead use embryonic human life for testing toxic compaunds.
Advertisement
BOSTON, Mass (LifeSiteNews.com) - General Electric has announced that it will use embryonic stem cells provided by Geron Corporation for the purpose of testing toxic effects of drug treatments.
GE issued a statement, attempting to preempt criticism over the decision, saying, "We acknowledge the considerable debate and take very seriously the ethical and societal issues associated with research using stem cells derived from embryonic or fetal tissue."
"We conduct our research in an ethically and scientifically responsible manner," the statement said.
However, embryonic stem cells have been the center of heated controversy since harvesting the cells requires the destruction of embryonic human beings.
But Geron Corporation indicates that in this case it believes that the ends justify the means.
"Up to three quarters of toxicity problems are not detected until preclinical or later stages of drug development and this significantly increases the cost of developing new drugs," Geron Corporation said in a press release, "Earlier detection of toxicity problems could reduce both overall drug development costs and potentially harmful patient exposure in clinical trials."
Konstantin Fielder, General Manager of Cell Technologies at GE Healthcare said that stem cells harvested from human embryos could even replace lab rats as the primary scientific testing method.
"Once you have human cells and you can get them in a standardized way, like you get right now your lab rats in a standardized way, you can actually do those experiments on those cells," he said.
Both GE and Geron have said that the stem cells to be used are listed on a National Institutes of Health registry, making them eligible for use in the United States.
Contact Information for General Electric:
https://www.ge.com/contact/contact_form.html?ref=http://www.ge.com/
Or by phone: (203) 373-2211
- - -
LifeSiteNews.com is a non-profit Internet service dedicated to issues of culture, life, and family. It was launched in September 1997. LifeSiteNews Daily News reports and information pages are used by numerous organizations and publications, educators, professionals and political, religious and life and family organization leaders and grassroots people across North America and internationally.
Comments
Not surprising this is happening, I knew that it wouldn't stop at using embryos for stem cell research. I wonder are these purposely being made or are they left over embryos from in-vitro fertilization? Not that Im not for using embryos left over from IVF, both is sickening.
RooForLife | 7/6/2009
I just sent GE an email stating my outrage at this horrific development. I also wrote that I would not be buying their products and would be encouraging others to do the same. Unfortunately, public opinion and money speaks louder than ethics seem to for them!
Keep praying and do not lose hope! We do win in the end! But let us pray to win these battles too!
Comments that include profanity, personal attacks, antisocial behavior such as "spamming" and "trolling," or other inappropriate comments or material will not be posted on Catholic Online. Comments are moderated and generally will be posted if they are on-topic and not abusive. We will take steps to block users who violate any of our terms of service. While Catholic Online invites robust discussion, we maintain the right to not print material that is patently false in its claims concerning the teaching of the Magisterium of the Catholic Church, overtly anti-Catholic or which, in the opinion of the moderator, are intended to mislead readers as to what the Catholic Church teaches. Comments DO NOT necessarily reflect the opinion or views of Catholic Online.
RSS | Make Catholic Online Your Homepage
